Myelodysplastic Syndrome

Legacy URL
/Myelodysplastic_Syndrome

Treatment Patterns in Older Patients With Myelodysplastic Syndromes: A Population-Based Analysis Reflecting the Real World

Thursday, February 16, 2023 - 1:13pm
Male doctor and female doctor sitting at a computer talking.

Biglycan as a Mediator of Proinflammatory Response and Target for MDS and sAML Therapy

Thursday, December 22, 2022 - 10:17am
Black female scientist performing work in a lab.

Five-Day Versus 7-Day Treatment Regimen With Azacitidine in Lower Risk Myelodysplastic Syndrome

Monday, December 12, 2022 - 2:10pm
Cancer Research

Common Drug Activates Oncogene of MDS & Leukemia

Thursday, September 29, 2022 - 2:50pm
Closeup of blood work in glass vials.

The ABNL-MARRO 001 Study: A Phase 1–2 Study of Randomly Allocated Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes

Monday, September 26, 2022 - 3:18pm
hospital

The Genetic Landscape of Germline DDX41 Variants Predisposing to Myeloid Neoplasms

Thursday, September 1, 2022 - 11:08am
light blood cell

Prolonged Isolated Thrombocytopenia After HSCT Has Prognostic Value in Myelodysplastic Syndromes

Monday, August 29, 2022 - 3:20pm
hospital room

Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS

Friday, August 12, 2022 - 8:59am
IV

Fibrinogen May Be Associated With Poor Prognosis in Myelodysplastic Syndrome

Wednesday, July 20, 2022 - 1:48pm
protein

Therapy-Related Clonal Cytopenia as a Precursor to Therapy-Related Myeloid Neoplasms

Tuesday, July 12, 2022 - 8:33am
DNA
Subscribe to Myelodysplastic Syndrome